bpc 157 human studies randomized clinical trial BPC-157: What the Science Actually Says The Stable Gastric Pentadecapeptide BPC
Description
Most reactions resolve spontaneously upon continued use or dose adjustment
Organs were homogenized in PBS using a Mixer Mill MM400 (Retsch) with 3.2-mm stainless steel beads (BioSpec) at 30 Hz for 2 min
Our BPC-157 peptide patches utilize cutting-edge transdermal delivery, ensuring consistent peptide absorption for reliable research applications
The first human safety study on health volunteers was conducted in 2002 and a phase 2 double blind, randomized clinical trial (small and not sufficient for US phase 2 purposes) was conducted in 2005 with BPC-157 enemas for ulcerative colitis, with some promising effects (see research name PL 14736 to find the references)
Why youll love it
